Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A3 | P48764 | 14/20 | 0.67 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31314045 | 1.00 | SLC9A3 (0.67) | SLC9A3SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL30353026 | 1.00 | SLC9A3 (0.67) | SLC9A3SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2575008 | 1.00 | SLC9A3 (0.67) | SLC9A3SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL29631407 | 1.00 | SLC9A3 (0.67) | SLC9A3SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL13286074 | 1.00 | SLC9A3 (0.67) | SLC9A3SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2573202 | 1.00 | SLC9A3 (0.67) | SLC9A3SLC6A2SLC6A4SLC6A3 | |
| Hydrochloric Acid SCHEMBL6501908 | 0.99 | SLC9A3 (0.65) | SLC9A3 | |
| Formic Acid SCHEMBL30353024 | 0.93 | SLC9A3 (0.62) | SLC9A3 | |
| SCHEMBL30435654 | 0.90 | SLC9A3 (0.57) | SLC9A3SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL30435872 | 0.89 | SLC9A3 (0.54) | SLC9A3SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119569588-A | Preparation method and intermediate of ilast hydrochloride | 杭州诺澳生物医药科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119390714-A | Methods and compounds | 雷迪厄斯制药公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-113348163-B | Methods and compounds | 雷迪厄斯制药公司 | 2024-10-08 | — | — | CN | disclosed |
| CN-114901663-B | Aromatic heterocyclic compounds and application thereof in medicines | 上海喆邺生物科技有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-114845997-B | Aromatic compound and application thereof in preparation of antitumor drugs | 上海喆邺生物科技有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-115052870-B | Aromatic compound and application thereof in antitumor drugs | 上海喆邺生物科技有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-116969848-A | Preparation method of intermediate of drug for treating advanced breast cancer | 北京康立生医药技术开发有限公司 | 2023-10-31 | — | — | CN | disclosed |
| EP-4194452-A1 | AROMATIC COMPOUND AND APPLICATION THEREOF IN ANTITUMOR DRUG | Shanghai Zheye Biotechnology Co., Ltd. (CN) | 2023-06-14 | — | — | EP | disclosed |
| US-20230159529-A1 | AROMATIC COMPOUND AND APPLICATION THEREOF IN ANTITUMOR DRUG | SHANGHAI ZHEYE BIOTECHNOLOGY CO., LTD. (CN) | 2023-05-25 | — | — | US | disclosed |
| CN-115052870-A | Aromatic compound and application thereof in antitumor drugs | 上海喆邺生物科技有限公司 | 2022-09-13 | — | — | CN | disclosed |
| CN-114901663-A | Heteroaromatic compound and application thereof in medicines | 上海喆邺生物科技有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-114845997-A | Aromatic compound and application thereof in preparation of antitumor drugs | 上海喆邺生物科技有限公司 | 2022-08-02 | — | — | CN | disclosed |
| CN-114585624-A | Chiral intermediate and preparation method thereof | 上海喆邺生物科技有限公司 | 2022-06-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159529-A1 | AROMATIC COMPOUND AND APPLICATION THEREOF IN ANTITUMOR DRUG | TYR, APC, TP53 | SLC9A3 3367/4885SLC6A2 782/4885SLC6A4 1011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.